MedPath

Elucidation of pathologic condition in patients with cerebrovascular disease or neurodegenerative disease using C-11 flumazenil PET

Not Applicable
Suspended
Conditions
Patients with or suspected cerebrovascular disease or neurodegenerative disease
Registration Number
JPRN-UMIN000043740
Lead Sponsor
Kagawa University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Patient judged unsuitable as a subject by a researcher

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SUV in disease using C-11 flumazenil PET
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath